ArticleBreast cancer research and treatment2025

Comment on ''patient preferences for CDK4/6 inhibitor treatments in HR + /HER2- early breast cancer: a discrete choice survey study''.

Wei Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.